Healthcare

Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials

WOBURN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their...

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/...

Alternative Credentials Market for Higher Education to Grow by USD 1.84 Billion (2025-2029), Driven by Skills Gap and AI Redefining the Market Landscape – Technavio

NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global alternative credentials market...

Wearable Robotics Leading Company WIRobotics to Introduce Ultra-Lightweight Walking Assistance Wearable Robot WIM to the U.S. Market

Revolutionizing Personal Mobility and Healthcare for All Ages Proven Innovation Backed by CES Awards and Success in the Korean Market...

error: Content is protected !!